These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 18430123

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Carbonic anhydrase IX and renal cell carcinoma: prognosis, response to systemic therapy, and future vaccine strategies.
    Shuch B, Li Z, Belldegrun AS.
    BJU Int; 2008 Jun; 101 Suppl 4():25-30. PubMed ID: 18430119
    [No Abstract] [Full Text] [Related]

  • 3. Carbonic anhydrase IX as a predictive biomarker of response to kidney cancer therapy.
    Signoretti S, Regan M, Atkins M.
    BJU Int; 2008 Jun; 101 Suppl 4():31-5. PubMed ID: 18430120
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Carbonic anhydrase IX and the future of molecular markers in renal cell carcinoma.
    Leppert JT, Lam JS, Pantuck AJ, Figlin RA, Belldegrun AS.
    BJU Int; 2005 Aug; 96(3):281-5. PubMed ID: 16042714
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy.
    Stillebroer AB, Mulders PF, Boerman OC, Oyen WJ, Oosterwijk E.
    Eur Urol; 2010 Jul; 58(1):75-83. PubMed ID: 20359812
    [Abstract] [Full Text] [Related]

  • 9. Carbonic anhydrase IX expression is associated with improved outcome of high-dose interleukin-2 therapy for metastatic renal cell carcinoma.
    Dudek AZ, Yee RT, Manivel JC, Isaksson R, Yee HO.
    Anticancer Res; 2010 Mar; 30(3):987-92. PubMed ID: 20393025
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Comment to "Immunohistochemical expression of microvascular density and carbonic anhidrase IX in renal carcinoma. Relation to histological type and tumoral progression"].
    Salinas AS.
    Actas Urol Esp; 2011 Feb; 35(2):87-8. PubMed ID: 21288602
    [No Abstract] [Full Text] [Related]

  • 12. Carbonic anhydrase IX as a specific biomarker for clear cell renal cell carcinoma: comparative study of Western blot and immunohistochemistry and implications for diagnosis.
    Giménez-Bachs JM, Salinas-Sánchez AS, Serrano-Oviedo L, Nam-Cha SH, Rubio-Del Campo A, Sánchez-Prieto R.
    Scand J Urol Nephrol; 2012 Oct; 46(5):358-64. PubMed ID: 22571179
    [Abstract] [Full Text] [Related]

  • 13. Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience.
    Lamers CH, Sleijfer S, Vulto AG, Kruit WH, Kliffen M, Debets R, Gratama JW, Stoter G, Oosterwijk E.
    J Clin Oncol; 2006 May 01; 24(13):e20-2. PubMed ID: 16648493
    [No Abstract] [Full Text] [Related]

  • 14. Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy.
    Choueiri TK, Regan MM, Rosenberg JE, Oh WK, Clement J, Amato AM, McDermott D, Cho DC, Atkins MB, Signoretti S.
    BJU Int; 2010 Sep 01; 106(6):772-8. PubMed ID: 20230385
    [Abstract] [Full Text] [Related]

  • 15. Carbonic anhydrase IX expression in clear cell renal cell carcinoma and normal tissues: experiences from (radio) immunotherapy.
    Brouwers AH, Mulders PF, Oyen WJ.
    J Clin Oncol; 2008 Aug 01; 26(22):3808-9; author reply 3811-2. PubMed ID: 18669472
    [No Abstract] [Full Text] [Related]

  • 16. In vivo molecular prediction of carbonic anhydrase IX-G250MN expression on immunotherapy outcome in renal cancer.
    Brouwers AH, Boerman OC, Oyen WJ.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8886; author reply 8886. PubMed ID: 16361579
    [No Abstract] [Full Text] [Related]

  • 17. The pathway to biomarker discovery: carbonic anhydrase IX and the prediction of immune responsiveness.
    Panelli MC, Wang E, Marincola FM.
    Clin Cancer Res; 2005 May 15; 11(10):3601-3. PubMed ID: 15897553
    [No Abstract] [Full Text] [Related]

  • 18. Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer.
    Li G, Feng G, Gentil-Perret A, Genin C, Tostain J.
    J Urol; 2008 Aug 15; 180(2):510-3; discussion 513-4. PubMed ID: 18550116
    [Abstract] [Full Text] [Related]

  • 19. Carbonic Anhydrase IX is not a predictor of outcomes in non-metastatic clear cell renal cell carcinoma - a digital analysis of tissue microarray.
    Zerati M, Leite KR, Pontes-Junior J, Segre CC, Reis ST, Srougi M, Dall'Oglio MF.
    Int Braz J Urol; 2013 Aug 15; 39(4):484-92. PubMed ID: 24054396
    [Abstract] [Full Text] [Related]

  • 20. The use of positron-emission tomography in the diagnosis of tumour phenotype.
    Divgi C.
    BJU Int; 2008 Jun 15; 101 Suppl 4():36-8. PubMed ID: 18430121
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.